AMERICAN JOURNAL OF HEMATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2177836, encodeId=a60d21e783615, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：急性髓系白血病 经验分享：拒稿贼快，好评了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d79115905, createdName=ms9000001761569470, createdTime=Thu Dec 28 17:39:14 CST 2023, time=2023-12-28, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=577951, encodeId=40bb5e79518e, content=CASE可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9002002921, createdName=杏花雨, createdTime=Tue Oct 15 15:14:00 CST 2019, time=2019-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086443, encodeId=7921108644384, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086444, encodeId=7d0a10864448a, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967432, encodeId=9d8996e432b5, content=投出去3天后状态从Assigning Editor变成Under Review，现在已经Under Review一周了，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99842164012, createdName=1203a3a3m69(暂无昵称), createdTime=Fri May 21 11:48:17 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498640, encodeId=1ad349864004, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿4天后拒稿。拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=796, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 27 10:39:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583322, encodeId=88545833225b, content=什么杂志求分享yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf92618806, createdName=kangll227, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563553, encodeId=6f6656355368, content=拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff8f2099865, createdName=yougre, createdTime=Fri Nov 23 00:00:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847604, encodeId=8fb184e60466, content=审稿速度:3.0 经验分享：今年很有可能会有更高的if，所以尝试投了一篇，希望可以有答复。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Oct 10 15:46:04 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526557, encodeId=133052655e7d, content=做的血液方面的临床研究，投这个怎么样？中国人中稿率多少？求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=706, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89211944741, createdName=谭123, createdTime=Tue Aug 30 21:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=)]

2023-12-28 ms9000001761569470 来自辽宁省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：急性髓系白血病
经验分享：拒稿贼快，好评了

158 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177836, encodeId=a60d21e783615, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：急性髓系白血病 经验分享：拒稿贼快，好评了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d79115905, createdName=ms9000001761569470, createdTime=Thu Dec 28 17:39:14 CST 2023, time=2023-12-28, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=577951, encodeId=40bb5e79518e, content=CASE可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9002002921, createdName=杏花雨, createdTime=Tue Oct 15 15:14:00 CST 2019, time=2019-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086443, encodeId=7921108644384, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086444, encodeId=7d0a10864448a, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967432, encodeId=9d8996e432b5, content=投出去3天后状态从Assigning Editor变成Under Review，现在已经Under Review一周了，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99842164012, createdName=1203a3a3m69(暂无昵称), createdTime=Fri May 21 11:48:17 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498640, encodeId=1ad349864004, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿4天后拒稿。拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=796, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 27 10:39:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583322, encodeId=88545833225b, content=什么杂志求分享yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf92618806, createdName=kangll227, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563553, encodeId=6f6656355368, content=拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff8f2099865, createdName=yougre, createdTime=Fri Nov 23 00:00:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847604, encodeId=8fb184e60466, content=审稿速度:3.0 经验分享：今年很有可能会有更高的if，所以尝试投了一篇，希望可以有答复。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Oct 10 15:46:04 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526557, encodeId=133052655e7d, content=做的血液方面的临床研究，投这个怎么样？中国人中稿率多少？求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=706, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89211944741, createdName=谭123, createdTime=Tue Aug 30 21:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=)]

2019-10-15 杏花雨

CASE可投吗

551 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177836, encodeId=a60d21e783615, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：急性髓系白血病 经验分享：拒稿贼快，好评了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d79115905, createdName=ms9000001761569470, createdTime=Thu Dec 28 17:39:14 CST 2023, time=2023-12-28, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=577951, encodeId=40bb5e79518e, content=CASE可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9002002921, createdName=杏花雨, createdTime=Tue Oct 15 15:14:00 CST 2019, time=2019-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086443, encodeId=7921108644384, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086444, encodeId=7d0a10864448a, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967432, encodeId=9d8996e432b5, content=投出去3天后状态从Assigning Editor变成Under Review，现在已经Under Review一周了，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99842164012, createdName=1203a3a3m69(暂无昵称), createdTime=Fri May 21 11:48:17 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498640, encodeId=1ad349864004, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿4天后拒稿。拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=796, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 27 10:39:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583322, encodeId=88545833225b, content=什么杂志求分享yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf92618806, createdName=kangll227, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563553, encodeId=6f6656355368, content=拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff8f2099865, createdName=yougre, createdTime=Fri Nov 23 00:00:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847604, encodeId=8fb184e60466, content=审稿速度:3.0 经验分享：今年很有可能会有更高的if，所以尝试投了一篇，希望可以有答复。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Oct 10 15:46:04 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526557, encodeId=133052655e7d, content=做的血液方面的临床研究，投这个怎么样？中国人中稿率多少？求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=706, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89211944741, createdName=谭123, createdTime=Tue Aug 30 21:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=)]

2021-12-29 小动量

为什么期刊要求用三线表/使用三线表的意义何在？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177836, encodeId=a60d21e783615, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：急性髓系白血病 经验分享：拒稿贼快，好评了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d79115905, createdName=ms9000001761569470, createdTime=Thu Dec 28 17:39:14 CST 2023, time=2023-12-28, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=577951, encodeId=40bb5e79518e, content=CASE可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9002002921, createdName=杏花雨, createdTime=Tue Oct 15 15:14:00 CST 2019, time=2019-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086443, encodeId=7921108644384, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086444, encodeId=7d0a10864448a, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967432, encodeId=9d8996e432b5, content=投出去3天后状态从Assigning Editor变成Under Review，现在已经Under Review一周了，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99842164012, createdName=1203a3a3m69(暂无昵称), createdTime=Fri May 21 11:48:17 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498640, encodeId=1ad349864004, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿4天后拒稿。拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=796, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 27 10:39:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583322, encodeId=88545833225b, content=什么杂志求分享yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf92618806, createdName=kangll227, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563553, encodeId=6f6656355368, content=拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff8f2099865, createdName=yougre, createdTime=Fri Nov 23 00:00:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847604, encodeId=8fb184e60466, content=审稿速度:3.0 经验分享：今年很有可能会有更高的if，所以尝试投了一篇，希望可以有答复。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Oct 10 15:46:04 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526557, encodeId=133052655e7d, content=做的血液方面的临床研究，投这个怎么样？中国人中稿率多少？求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=706, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89211944741, createdName=谭123, createdTime=Tue Aug 30 21:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=)]

2021-12-28 rayms

什么时候使用柱状图，什么时候使用折线图？

332 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177836, encodeId=a60d21e783615, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：急性髓系白血病 经验分享：拒稿贼快，好评了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d79115905, createdName=ms9000001761569470, createdTime=Thu Dec 28 17:39:14 CST 2023, time=2023-12-28, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=577951, encodeId=40bb5e79518e, content=CASE可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9002002921, createdName=杏花雨, createdTime=Tue Oct 15 15:14:00 CST 2019, time=2019-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086443, encodeId=7921108644384, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086444, encodeId=7d0a10864448a, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967432, encodeId=9d8996e432b5, content=投出去3天后状态从Assigning Editor变成Under Review，现在已经Under Review一周了，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99842164012, createdName=1203a3a3m69(暂无昵称), createdTime=Fri May 21 11:48:17 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498640, encodeId=1ad349864004, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿4天后拒稿。拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=796, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 27 10:39:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583322, encodeId=88545833225b, content=什么杂志求分享yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf92618806, createdName=kangll227, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563553, encodeId=6f6656355368, content=拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff8f2099865, createdName=yougre, createdTime=Fri Nov 23 00:00:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847604, encodeId=8fb184e60466, content=审稿速度:3.0 经验分享：今年很有可能会有更高的if，所以尝试投了一篇，希望可以有答复。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Oct 10 15:46:04 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526557, encodeId=133052655e7d, content=做的血液方面的临床研究，投这个怎么样？中国人中稿率多少？求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=706, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89211944741, createdName=谭123, createdTime=Tue Aug 30 21:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=)]

2021-05-21 1203a3a3m69(暂无昵称)

投出去3天后状态从Assigning Editor变成Under Review，现在已经Under Review一周了，希望有好消息

335 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177836, encodeId=a60d21e783615, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：急性髓系白血病 经验分享：拒稿贼快，好评了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d79115905, createdName=ms9000001761569470, createdTime=Thu Dec 28 17:39:14 CST 2023, time=2023-12-28, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=577951, encodeId=40bb5e79518e, content=CASE可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9002002921, createdName=杏花雨, createdTime=Tue Oct 15 15:14:00 CST 2019, time=2019-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086443, encodeId=7921108644384, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086444, encodeId=7d0a10864448a, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967432, encodeId=9d8996e432b5, content=投出去3天后状态从Assigning Editor变成Under Review，现在已经Under Review一周了，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99842164012, createdName=1203a3a3m69(暂无昵称), createdTime=Fri May 21 11:48:17 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498640, encodeId=1ad349864004, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿4天后拒稿。拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=796, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 27 10:39:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583322, encodeId=88545833225b, content=什么杂志求分享yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf92618806, createdName=kangll227, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563553, encodeId=6f6656355368, content=拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff8f2099865, createdName=yougre, createdTime=Fri Nov 23 00:00:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847604, encodeId=8fb184e60466, content=审稿速度:3.0 经验分享：今年很有可能会有更高的if，所以尝试投了一篇，希望可以有答复。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Oct 10 15:46:04 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526557, encodeId=133052655e7d, content=做的血液方面的临床研究，投这个怎么样？中国人中稿率多少？求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=706, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89211944741, createdName=谭123, createdTime=Tue Aug 30 21:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=)]

2013-08-27 匿名用户

审稿速度:1.0 | 投稿命中率:25.0
经验分享：审稿4天后拒稿。拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%.

796 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2177836, encodeId=a60d21e783615, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：急性髓系白血病 经验分享：拒稿贼快，好评了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d79115905, createdName=ms9000001761569470, createdTime=Thu Dec 28 17:39:14 CST 2023, time=2023-12-28, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=577951, encodeId=40bb5e79518e, content=CASE可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9002002921, createdName=杏花雨, createdTime=Tue Oct 15 15:14:00 CST 2019, time=2019-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086443, encodeId=7921108644384, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086444, encodeId=7d0a10864448a, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967432, encodeId=9d8996e432b5, content=投出去3天后状态从Assigning Editor变成Under Review，现在已经Under Review一周了，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99842164012, createdName=1203a3a3m69(暂无昵称), createdTime=Fri May 21 11:48:17 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498640, encodeId=1ad349864004, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿4天后拒稿。拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=796, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 27 10:39:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583322, encodeId=88545833225b, content=什么杂志求分享yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf92618806, createdName=kangll227, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563553, encodeId=6f6656355368, content=拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff8f2099865, createdName=yougre, createdTime=Fri Nov 23 00:00:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847604, encodeId=8fb184e60466, content=审稿速度:3.0 经验分享：今年很有可能会有更高的if，所以尝试投了一篇，希望可以有答复。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Oct 10 15:46:04 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526557, encodeId=133052655e7d, content=做的血液方面的临床研究，投这个怎么样？中国人中稿率多少？求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=706, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89211944741, createdName=谭123, createdTime=Tue Aug 30 21:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=)]

2020-01-14 kangll227

什么杂志求分享yougre 2018-11-23 00:00:00 发表:
拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧

yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧

457 0

[GetPortalCommentsPageByObjectIdResponse(id=2177836, encodeId=a60d21e783615, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：急性髓系白血病 经验分享：拒稿贼快，好评了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d79115905, createdName=ms9000001761569470, createdTime=Thu Dec 28 17:39:14 CST 2023, time=2023-12-28, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=577951, encodeId=40bb5e79518e, content=CASE可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9002002921, createdName=杏花雨, createdTime=Tue Oct 15 15:14:00 CST 2019, time=2019-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086443, encodeId=7921108644384, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086444, encodeId=7d0a10864448a, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967432, encodeId=9d8996e432b5, content=投出去3天后状态从Assigning Editor变成Under Review，现在已经Under Review一周了，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99842164012, createdName=1203a3a3m69(暂无昵称), createdTime=Fri May 21 11:48:17 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498640, encodeId=1ad349864004, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿4天后拒稿。拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=796, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 27 10:39:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583322, encodeId=88545833225b, content=什么杂志求分享yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf92618806, createdName=kangll227, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563553, encodeId=6f6656355368, content=拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff8f2099865, createdName=yougre, createdTime=Fri Nov 23 00:00:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847604, encodeId=8fb184e60466, content=审稿速度:3.0 经验分享：今年很有可能会有更高的if，所以尝试投了一篇，希望可以有答复。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Oct 10 15:46:04 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526557, encodeId=133052655e7d, content=做的血液方面的临床研究，投这个怎么样？中国人中稿率多少？求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=706, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89211944741, createdName=谭123, createdTime=Tue Aug 30 21:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=)]

2018-11-23 yougre

拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧

575 0

[GetPortalCommentsPageByObjectIdResponse(id=2177836, encodeId=a60d21e783615, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：急性髓系白血病 经验分享：拒稿贼快，好评了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d79115905, createdName=ms9000001761569470, createdTime=Thu Dec 28 17:39:14 CST 2023, time=2023-12-28, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=577951, encodeId=40bb5e79518e, content=CASE可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9002002921, createdName=杏花雨, createdTime=Tue Oct 15 15:14:00 CST 2019, time=2019-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086443, encodeId=7921108644384, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086444, encodeId=7d0a10864448a, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967432, encodeId=9d8996e432b5, content=投出去3天后状态从Assigning Editor变成Under Review，现在已经Under Review一周了，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99842164012, createdName=1203a3a3m69(暂无昵称), createdTime=Fri May 21 11:48:17 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498640, encodeId=1ad349864004, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿4天后拒稿。拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=796, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 27 10:39:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583322, encodeId=88545833225b, content=什么杂志求分享yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf92618806, createdName=kangll227, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563553, encodeId=6f6656355368, content=拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff8f2099865, createdName=yougre, createdTime=Fri Nov 23 00:00:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847604, encodeId=8fb184e60466, content=审稿速度:3.0 经验分享：今年很有可能会有更高的if，所以尝试投了一篇，希望可以有答复。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Oct 10 15:46:04 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526557, encodeId=133052655e7d, content=做的血液方面的临床研究，投这个怎么样？中国人中稿率多少？求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=706, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89211944741, createdName=谭123, createdTime=Tue Aug 30 21:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=)]

2018-10-10 ms982570025122324

审稿速度:3.0
经验分享：今年很有可能会有更高的if，所以尝试投了一篇，希望可以有答复。

429 0

[GetPortalCommentsPageByObjectIdResponse(id=2177836, encodeId=a60d21e783615, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：急性髓系白血病 经验分享：拒稿贼快，好评了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88d79115905, createdName=ms9000001761569470, createdTime=Thu Dec 28 17:39:14 CST 2023, time=2023-12-28, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=577951, encodeId=40bb5e79518e, content=CASE可投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=551, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9002002921, createdName=杏花雨, createdTime=Tue Oct 15 15:14:00 CST 2019, time=2019-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086443, encodeId=7921108644384, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086444, encodeId=7d0a10864448a, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967432, encodeId=9d8996e432b5, content=投出去3天后状态从Assigning Editor变成Under Review，现在已经Under Review一周了，希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99842164012, createdName=1203a3a3m69(暂无昵称), createdTime=Fri May 21 11:48:17 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498640, encodeId=1ad349864004, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿4天后拒稿。拒稿信里提及：You will appreciate the fact that AJH has an overall acceptance rate of < 25%., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=796, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 27 10:39:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583322, encodeId=88545833225b, content=什么杂志求分享yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=yougre 2018-11-23 00:00:00 发表: 拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf92618806, createdName=kangll227, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563553, encodeId=6f6656355368, content=拒稿效率很高，不耽误时间，编辑强烈推荐我去转投另外一份3分杂志，转投之后版面费也给打8折，目前已转投10天，还没有消息回来，不过没有消息就是最好的消息吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff8f2099865, createdName=yougre, createdTime=Fri Nov 23 00:00:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847604, encodeId=8fb184e60466, content=审稿速度:3.0 经验分享：今年很有可能会有更高的if，所以尝试投了一篇，希望可以有答复。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Oct 10 15:46:04 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526557, encodeId=133052655e7d, content=做的血液方面的临床研究，投这个怎么样？中国人中稿率多少？求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=706, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89211944741, createdName=谭123, createdTime=Tue Aug 30 21:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=)]

2016-08-30 谭123

做的血液方面的临床研究，投这个怎么样？中国人中稿率多少？求大神指导

706 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务